Ilan Ganot - 03 Jan 2023 Form 4 Insider Report for Solid Biosciences Inc. (SLDB)

Role
Director
Signature
/s/ David Tyronne Howton as attorney-in-fact for Ilan Ganot
Issuer symbol
SLDB
Transactions as of
03 Jan 2023
Net transactions value
$0
Form type
4
Filing time
05 Jan 2023, 20:45:48 UTC
Previous filing
05 Dec 2022
Next filing
31 Jan 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SLDB Employee Stock Option (Right to Buy) Award $0 +23,950 $0.000000 23,950 03 Jan 2023 Common Stock 23,950 $5.62 Spouse F1
transaction SLDB Restricted Stock Units Award $0 +11,975 $0.000000 11,975 03 Jan 2023 Common Stock 11,975 Spouse F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on January 3, 2023 (the "Grant Date") and vests over four years, with 25% of the original number of shares vesting on the first anniversary of the Grant Date and 2.0833% of the original number of shares on the first day of each calendar month thereafter until the fourth such anniversary.
F2 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the "RSUs").
F3 The RSUs were granted on the Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary.